title: Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers.
authors: Richmond Pharmacology Ltd, St George's University of London, Cranmer Terrace, Tooting, London, SW17 0RE, UK. a.naseem@richmondpharmacology.com
authors: Asif
authors: A
authors: Naseem
authors: Tomohiko
authors: T
authors: Harada
authors: Duolao
authors: D
authors: Wang
authors: Radivoj
authors: R
authors: Arezina
authors: Ulrike
authors: U
authors: Lorch
authors: Erol
authors: E
authors: Onel
authors: Alan John
authors: AJ
authors: Camm
authors: Jorg
authors: J
authors: Taubel
mesh_terms: D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage*; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001372:Aza Compounds / Q000008:administration & dosage; D002045:Bupivacaine / Q000008:administration & dosage*; D018592:Cross-Over Studies; D003692:Delayed-Action Preparations / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008081:Liposomes; D008133:Long QT Syndrome; D008297:Male; D000077266:Moxifloxacin; D011804:Quinolines / Q000008:administration & dosage
chemical_list: D000779:Anesthetics, Local; D000890:Anti-Infective Agents; D001372:Aza Compounds; D003692:Delayed-Action Preparations; D024841:Fluoroquinolones; D008081:Liposomes; D011804:Quinolines; D000077266:Moxifloxacin; D002045:Bupivacaine